Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging

Journal of Alzheimer's Disease

Volumn 47, Issue 1, 2015, Pages 167-176

  Zhao, Qianhua ^a   Roberts, Rosebud O ^b   Ding, Ding ^a   Cha, Ruth ^b   Guo, Qihao ^a   Meng, Haijiao ^a   Luo, Jianfeng ^c   Machulda, Mary M ^b   Shane Pankratz, V ^b   Wang, Bei ^a   Christianson, Teresa J H ^b   Aakre, Jeremiah A ^b   Knopman, David S ^b   Boeve, Bradley F ^b   Hong, Zhen ^a   Petersen, Ronald C ^b  

^a FUDAN UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cognition; Cross sectional studies; Diabetes mellitus; Executive function

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINESE; COGNITIVE DEFECT; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HETEROZYGOTE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEMORY; OBESITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKILL; VASCULAR DISEASE; AGING; CHINA; COGNITION DISORDERS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; GENETICS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; UNITED STATES;

AGED; AGING; APOLIPOPROTEINS E; CHINA; COGNITION DISORDERS; COHORT STUDIES; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EXECUTIVE FUNCTION; FEMALE; HUMANS; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; UNITED STATES;

EID: 84940906516     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150073     Document Type: Article

References (42)

1. Biessels GJ, Deary IJ, Ryan CM (2008) Cognition and diabetes: A lifespan perspective. Lancet Neurol 7, 184-190.
2. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
3. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, BretelerMM(1999) Diabetes mellitus and the risk of dementia: The rotterdam study. Neurology 53, 1937-1942.
4. Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S,Touchon J, RitchieK(2008) Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 79, 979-984.
5. Atti AR, Forlani C, De Ronchi D, Palmer K, Casadio P, Dalmonte E, Fratiglioni L (2010) Cognitive impairment after age 60: Clinical and social correlates in the Faenza Project. J Alzheimers Dis 21, 1325-1334.
6. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC (2008) Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 65, 1066-1073.
7. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891.
8. Luck T, Luppa M, Briel S, Matschinger H, Konig HH, Bleich S, Villringer A, Angermeyer MC, Riedel-Heller SG (2010) Mild cognitive impairment: Incidence and risk factors: Results of the leipzig longitudinal study of the aged. J Am Geriatr Soc 58, 1903-1910.
9. Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, PetersenRC(2014) Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 10, 18-26.
10. MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14, 77-83.
11. Ding D, Zhao Q, Guo Q, Meng H,Wang B, Yu P, Luo J, Zhou Y, Yu L, Zheng L, Chu S, Mortimer JA, Borenstein AR, Hong Z (2014) The Shanghai Aging Study: Study design, baseline characteristics, and prevalence of dementia. Neuroepidemiology 43, 114-122.
12. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA (2008) The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30, 58-69.
13. Ding D, Zhao Q, Guo Q, Meng H, Wang B, Luo J, Mortimer JA, Borenstein AR, Hong Z (2015) Prevalence of mild cognitive impairment in an urban community in China: A cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement 11, 300-309.e2.
14. Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA (2010) Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 75, 889-897.
15. Guo Q, Zhao Q, Chen M, Ding D, Hong Z (2009) A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord 23, 253-259.
16. Lezak MD HD, Loring DW ed (2004) Neuropsychological Assessment, 4th Edition, Oxford University Press, New York.
17. RMR (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skill 8, 6.
18. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: A frontal assessment battery at bedside. Neurology 55, 1621-1626.
19. Kaplan EF, Goodglass H, Weintraub S (1982) The Boston Naming Test, 2nd edition, Lea & Febiger, Philadelphia.
20. Ivnik RJ MJ, Smith GE, et al. (1992) WAISR, WMS-R and AVLT norms for ages 56 through 97. Clin Neuropsycho 6, 104.
21. Wechsler D (1987)Wechsler Memory Scale-Revised, Psychological Corporation, New York.
22. Wechsler D (1987) Wechsler Adult Intelligence Scale- Revised, Psychological Corporation, New York.
23. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Graff-Radford NR, Petersen RC (1998) Mayo's older Americans normative studies: Category fluency norms. J Clin Exp Neuropsychol 20, 194-200.
24. Morey SC (1997) ADA recommends a lower fasting glucose value in the diagnosis of diabetes mellitus. Am Fam Physician 56, 2128, 2130.
25. Koch W,EhrenhaftA,GriesserK,PfeuferA,MullerJ,Schomig A, Kastrati A (2002) TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 40, 1123-1131.
26. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
27. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. American Psychiatric Association, Washington, DC.
28. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
29. (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157-163.
30. McCrimmon RJ, Ryan CM, Frier BM (2012) Diabetes and cognitive dysfunction. Lancet 379, 2291-2299.
31. Nguyen HT, Arcury TA, Grzywacz JG, Saldana SJ, Ip EH, Kirk JK, Bell RA, Quandt SA (2012) The association of mental conditions with blood glucose levels in older adults with diabetes. Aging Ment Health 16, 950-957.
32. Saczynski JS, Jonsdottir MK,GarciaME,JonssonPV, Peila R, Eiriksdottir G, Olafsdottir E, Harris TB, Gudnason V, Launer LJ (2008) Cognitive impairment: An increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol 168, 1132-1139.
33. Alvarenga PP, Pereira DS, Anjos DM (2010) Functional mobility and executive function in elderly diabetics and nondiabetics. Rev Bras Fisioter 14, 491-496.
34. Goh DA DY, Lee WY, Koay WI, Tay SZ, Soon D, Chen C, Brittain CF, Lowe SL,Wong BS (2014)Apilot study to examine the correlation between cognition and blood biomarkers in a Singapore Chinese male cohort with type 2 diabetes mellitus. PLoS One 9, e96874.
35. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69, 1170-1175.
36. Grodstein F, Chen J,Wilson RS, Manson JE (2001)Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24, 1060-1065.
37. Luchsinger JA, Reitz C, Patel B, Tang MX,Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570-575.
38. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett- Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658-663.
39. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ (2010) A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53, 58-65.
40. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ (2010) Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26, 507-519.
41. Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, Rocca WA, Petersen RC, Jack CR Jr (2014) Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82, 1132-1141.
42. Palta P, Schneider AL, Biessels GJ, Touradji P, Hill-Briggs F (2014) Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc 20, 278-291.